Gene · 3036
Papers4,320
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
961 to 980 of 4,320
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Radiopharmaceutical Labelling for Lung Ventilation/Perfusion PET/CT Imaging: A Review of Production and Optimization Processes for Clinical Use. | Pharmaceuticals (Basel) | 2022 | 35631345 | PubTator, text mining | PubMed |
| Special Issue: Present and Future of Personalised Medicine for Endocrine Cancers. | J Pers Med | 2022 | 35629133 | PubTator, text mining | PubMed |
| Fatty Acid Fingerprints and Hyaluronic Acid in Extracellular Vesicles from Proliferating Human Fibroblast-like Synoviocytes. | Int J Mol Sci | 2022 | 35628422 | PubTator, text mining | PubMed |
| Consensus Gene Co-Expression Network Analysis Identifies Novel Genes Associated with Severity of Fibrotic Lung Disease. | Int J Mol Sci | 2022 | 35628257 | PubTator, text mining | PubMed |
| Hsa_circ_0006692 Promotes Lung Cancer Progression via miR-205-5p/CDK19 Axis. | Genes (Basel) | 2022 | 35627232 | PubTator, text mining | PubMed |
| Using GPCRs as Molecular Beacons to Target Ovarian Cancer with Nanomedicines. | Cancers (Basel) | 2022 | 35625966 | PubTator, text mining | PubMed |
| Lung Hyaluronasome: Involvement of Low Molecular Weight Ha (Lmw-Ha) in Innate Immunity. | Biomolecules | 2022 | 35625586 | PubTator, text mining | PubMed |
| Systemic Delivery of an Adjuvant CXCR4-CXCL12 Signaling Inhibitor Encapsulated in Synthetic Protein Nanoparticles for Glioma Immunotherapy. | ACS Nano | 2022 | 35616289 | PubTator, text mining | PubMed |
| Survival, cost and added therapeutic benefit of drugs granted early access through the French temporary authorization for use program in solid tumors from 2009 to 2019. | Int J Cancer | 2022 | 35603979 | PubTator, text mining | PubMed |
| Investigation of effective natural inhibitors for starch hydrolysing enzymes from Simaroubaceae plants by molecular docking analysis and comparison with in-vitro studies. | Heliyon | 2022 | 35600433 | PubTator, text mining | PubMed |
| Mir-675-5p supports hypoxia-induced drug resistance in colorectal cancer cells. | BMC Cancer | 2022 | 35596172 | PubTator, text mining | PubMed |
| Influenza chimeric hemagglutinin structures in complex with broadly protective antibodies to the stem and trimer interface. | Proc Natl Acad Sci U S A | 2022 | 35594401 | PubTator, text mining | PubMed |
| Human Identical Sequences, hyaluronan, and hymecromone ─ the new mechanism and management of COVID-19. | Mol Biomed | 2022 | 35593963 | PubTator, text mining | PubMed |
| Atrial fibrillation in cancer patients who develop stroke. | Cardiooncology | 2022 | 35585638 | PubTator, text mining | PubMed |
| The interactions between Reactive Black 5 and human serum albumin: combined spectroscopic and molecular dynamics simulation approaches. | Environ Sci Pollut Res Int | 2022 | 35583763 | PubTator, text mining | PubMed |
| Contribution of Deep-Learning Techniques Toward Fighting COVID-19: A Bibliometric Analysis of Scholarly Production During 2020. | IEEE Access | 2022 | 35582497 | PubTator, text mining | PubMed |
| The Computational Analysis of Single Nucleotide Associated with MicroRNA Affecting Hepatitis B Infection. | Microrna | 2022 | 35579134 | PubTator, text mining | PubMed |
| CircRNA has_circ_0069313 induced OSCC immunity escape by miR-325-3p-Foxp3 axes in both OSCC cells and Treg cells. | Aging (Albany NY) | 2022 | 35575762 | PubTator, text mining | PubMed |
| MCF10CA Breast Cancer Cells Utilize Hyaluronan-Coated EV-Rich Trails for Coordinated Migration. | Front Oncol | 2022 | 35574334 | PubTator, text mining | PubMed |
| Crosstalk between CD4 T cells and synovial fibroblasts from human arthritic joints promotes hyaluronan-dependent leukocyte adhesion and inflammatory cytokine expression in vitro. | Matrix Biol Plus | 2022 | 35573706 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3036/papers?page=49